A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2020; you can also visit the original URL.
The file type is application/pdf
.
P726The selective rho kinase inhibitor trans-6-((4-aminocyclohexyl)amino)-5-fluoro-2-methoxynicotinamide ameliorates monocrotaline-induced pulmonary hypertension
2017
European Heart Journal
Whether exercise limitation in chronic thromboembolic pulmonary vascular disease (CTEPVD) is predominantly caused by increased dead space ventilation or impaired cardiac reserve is still a matter of debate. Purpose: To determine the relative contribution of impaired right (RV) of left ventricular (LV) contractile reserve, abnormal pulmonary vascular reserve or increased dead space ventilation on exercise capacity. Methods: Fifty-three subjects [12 controls and 41 CTEPVD patients with (n=28) or
doi:10.1093/eurheartj/ehx501.p726
fatcat:455yj43pd5c6vkvvwdkbguqs7y